Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Colchicine in T2DM with Microalbuminuria: Chongqing Study
NCT02035891Unknown
- Sponsor
- Chongqing Medical University
- Start
- Dec 2013
- Primary completion
- Sep 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in diabetic nephropathy (DN) comparing Colchicine with Placebo (2 arms). Primary endpoint: The incidence of overt nephropathy at 3 years. Status: unknown.
02
Drugs
colchicine
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02035891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035891.